Table 5.
Propensity score matching analysis
| Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|
| Low ANLR | High ANLR | Low ANLR | High ANLR | |||
| Items | n = 1239 | n = 294 | P | n = 76 | n = 76 | P |
| Age (years), mean (SD) | 50.64(9.19) | 49.18(9.14) | 0.016 | 49.37(9.08) | 49.45(9.24) | 0.717 |
| BMI (Kg/m2), mean (SD) | 25.27(5.32) | 24.15(3.69) | 0.001 | 24.44(4.26) | 24.28(3.72) | 0.608 |
| Menopause, n (%) | 0.864 | 0.138 | ||||
| Yes | 114(9.2) | 28(9.5) | 7(9.2) | 9(11.8) | ||
| No | 1125(90.8) | 266(90.5) | 69(90.8) | 67(88.2) | ||
| Family history, n (%) | < 0.001 | 0.351 | ||||
| Yes | 565(45.6) | 184(62.6) | 37(48.7) | 36(47.4) | ||
| No | 674(54.4) | 110(37.4) | 39(51.3) | 40(52.6) | ||
| Blood type, n (%) | 0.136 | 0.762 | ||||
| A | 483(39.0) | 101(34.4) | 28(36.8) | 29(38.2) | ||
| B | 319(25.7) | 68(23.1) | 18(23.7) | 17(22.4) | ||
| AB | 115(9.3) | 35(11.9) | 7(9.2) | 8(10.5) | ||
| O | 322(26.0) | 90(30.6) | 23(30.3) | 22(28.9) | ||
| Tumor site, n (%) | 0.063 | 0.209 | ||||
| Right | 574(46.3) | 105(35.7) | 34(44.7) | 32(42.1) | ||
| Left | 665(53.7) | 189(64.3) | 42(55.3) | 44(57.9) | ||
| PLN, n (%) | 0.002 | 0.091 | ||||
| Positive | 748(60.4) | 206(70.1) | 51(67.1) | 49(64.3) | ||
| Negative | 491(39.6) | 88(29.9) | 25(32.9) | 27(35.7) | ||
| Tumor size, n (%) | < 0.001 | 0.155 | ||||
| < 30 mm | 531(42.9) | 83(28.2) | 24(31.6) | 22(28.9) | ||
| 30–50 mm | 526(42.5) | 111(37.8) | 31(40.8) | 31(40.8) | ||
| > 50 mm | 182(14.6) | 100(34.0) | 21(27.6) | 23(30.3) | ||
| Histological Grading, n (%) | < 0.001 | 0.537 | ||||
| Grade I | 263(21.2) | 33(11.2) | 12(15.8) | 11(14.5) | ||
| Grade II | 864(69.7) | 216(73.5) | 57(75.0) | 57(75.0) | ||
| Grade III | 112(9.1) | 45(15.3) | 7(9.2) | 8(10.5) | ||
| TNM stage, n (%) | < 0.001 | 0.766 | ||||
| II | 668(53.9) | 103(35.0) | 40(52.6) | 39(51.3) | ||
| III | 571(46.1) | 191(65.0) | 36(47.4) | 37(48.7) | ||
PSM: Propensity score matching; ANLR: Alb and Neutrophil-Lymphocyte Ratio; BMI: Body mass index; LNP: lymph node positivity